Titre : Facteurs cord

Facteurs cord : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Accuracy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteurs cord : Questions médicales les plus fréquentes", "headline": "Facteurs cord : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteurs cord : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-17", "dateModified": "2025-04-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteurs cord" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Toxines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001427", "about": { "@type": "MedicalCondition", "name": "Toxines bactériennes", "code": { "@type": "MedicalCode", "code": "D001427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123" } } }, "about": { "@type": "MedicalCondition", "name": "Facteurs cord", "alternateName": "Cord Factors", "code": { "@type": "MedicalCode", "code": "D003311", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Qian Wu", "url": "https://questionsmedicales.fr/author/Qian%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Acupuncture and Moxibustion, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China." } }, { "@type": "Person", "name": "E Bárbara-Bataller", "url": "https://questionsmedicales.fr/author/E%20B%C3%A1rbara-Bataller", "affiliation": { "@type": "Organization", "name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain. Electronic address: ebb31604@hotmail.com." } }, { "@type": "Person", "name": "J L Méndez-Suárez", "url": "https://questionsmedicales.fr/author/J%20L%20M%C3%A9ndez-Su%C3%A1rez", "affiliation": { "@type": "Organization", "name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain." } }, { "@type": "Person", "name": "C Alemán-Sánchez", "url": "https://questionsmedicales.fr/author/C%20Alem%C3%A1n-S%C3%A1nchez", "affiliation": { "@type": "Organization", "name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain." } }, { "@type": "Person", "name": "P Peñaloza-Polo", "url": "https://questionsmedicales.fr/author/P%20Pe%C3%B1aloza-Polo", "affiliation": { "@type": "Organization", "name": "Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37752614", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13049-023-01118-5" } }, { "@type": "ScholarlyArticle", "name": "Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37759205", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09965-9" } }, { "@type": "ScholarlyArticle", "name": "Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-023-05558-9" } }, { "@type": "ScholarlyArticle", "name": "Thirty-three myths and misconceptions about population data: from data capture and processing to linkage.", "datePublished": "2023-01-31", "url": "https://questionsmedicales.fr/article/37636835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23889/ijpds.v8i1.2115" } }, { "@type": "ScholarlyArticle", "name": "Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.", "datePublished": "2024-09-06", "url": "https://questionsmedicales.fr/article/39236329", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26635/6965.6445" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Toxines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001427" }, { "@type": "ListItem", "position": 5, "name": "Facteurs cord", "item": "https://questionsmedicales.fr/mesh/D003311" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteurs cord - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteurs cord", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteurs cord", "description": "Comment diagnostiquer une infection par Cord Factors ?\nQuels tests sont utilisés pour détecter les Cord Factors ?\nLes Cord Factors sont-ils visibles sur une radiographie ?\nPeut-on identifier les Cord Factors par PCR ?\nQuels symptômes peuvent indiquer une infection par Cord Factors ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Accuracy&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteurs cord", "description": "Quels sont les symptômes d'une infection par Cord Factors ?\nLes Cord Factors provoquent-ils des symptômes immédiats ?\nY a-t-il des symptômes spécifiques aux Cord Factors ?\nComment les symptômes évoluent-ils avec les Cord Factors ?\nLes Cord Factors causent-ils des douleurs thoraciques ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Accuracy&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteurs cord", "description": "Comment prévenir une infection par Cord Factors ?\nLa vaccination est-elle efficace contre les Cord Factors ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir l'infection par Cord Factors ?\nLes tests de dépistage sont-ils importants pour la prévention ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Accuracy&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteurs cord", "description": "Quel est le traitement standard pour une infection par Cord Factors ?\nLes Cord Factors nécessitent-ils un traitement prolongé ?\nY a-t-il des traitements alternatifs pour les Cord Factors ?\nLes Cord Factors sont-ils résistants aux antibiotiques ?\nComment surveiller l'efficacité du traitement des Cord Factors ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Accuracy&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteurs cord", "description": "Quelles complications peuvent survenir avec les Cord Factors ?\nLes Cord Factors peuvent-ils causer des infections systémiques ?\nComment les complications affectent-elles le traitement ?\nLes complications sont-elles fréquentes avec les Cord Factors ?\nQuelles sont les conséquences à long terme des Cord Factors ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Accuracy&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteurs cord", "description": "Quels sont les principaux facteurs de risque pour les Cord Factors ?\nLe VIH augmente-t-il le risque d'infection par Cord Factors ?\nLes personnes âgées sont-elles plus à risque ?\nLe voyage dans des zones endommagées augmente-t-il le risque ?\nLe contact avec des personnes infectées est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Accuracy&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Cord Factors ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests microbiologiques et des cultures de Mycobacterium." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les Cord Factors ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture et des tests sérologiques peuvent être utilisés pour détecter les Cord Factors." } }, { "@type": "Question", "name": "Les Cord Factors sont-ils visibles sur une radiographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, les Cord Factors ne sont pas visibles sur une radiographie, mais les effets de l'infection le sont." } }, { "@type": "Question", "name": "Peut-on identifier les Cord Factors par PCR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la PCR peut être utilisée pour identifier les gènes associés aux Cord Factors." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une infection par Cord Factors ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux persistante, fièvre, et perte de poids, mais varient selon l'individu." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par Cord Factors ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux, fièvre, sueurs nocturnes et fatigue, souvent liés à la tuberculose." } }, { "@type": "Question", "name": "Les Cord Factors provoquent-ils des symptômes immédiats ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, les symptômes peuvent prendre du temps à apparaître après l'infection initiale." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux Cord Factors ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes sont généralement ceux de la tuberculose, sans spécificité pour les Cord Factors." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec les Cord Factors ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec le temps si l'infection n'est pas traitée." } }, { "@type": "Question", "name": "Les Cord Factors causent-ils des douleurs thoraciques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs thoraciques peuvent survenir en raison de l'infection pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir une infection par Cord Factors ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut la vaccination BCG et des mesures d'hygiène pour éviter la transmission." } }, { "@type": "Question", "name": "La vaccination est-elle efficace contre les Cord Factors ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG peut réduire le risque de tuberculose, mais n'est pas toujours efficace." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter le contact avec des personnes infectées sont essentiels." } }, { "@type": "Question", "name": "Les masques aident-ils à prévenir l'infection par Cord Factors ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, porter un masque peut réduire le risque de transmission dans les zones à risque." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils importants pour la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce permet d'identifier et de traiter les infections rapidement." } }, { "@type": "Question", "name": "Quel est le traitement standard pour une infection par Cord Factors ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des antibiotiques comme l'isoniazide et la rifampicine." } }, { "@type": "Question", "name": "Les Cord Factors nécessitent-ils un traitement prolongé ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement peut durer plusieurs mois pour éradiquer complètement l'infection." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs pour les Cord Factors ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs existent, mais ils doivent être prescrits par un médecin." } }, { "@type": "Question", "name": "Les Cord Factors sont-ils résistants aux antibiotiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines souches de Mycobacterium peuvent développer une résistance aux antibiotiques." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement des Cord Factors ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est surveillée par des tests de culture et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les Cord Factors ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la pneumonie, la pleurésie et la dissémination de l'infection." } }, { "@type": "Question", "name": "Les Cord Factors peuvent-ils causer des infections systémiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une infection non traitée peut se propager et causer des infections systémiques graves." } }, { "@type": "Question", "name": "Comment les complications affectent-elles le traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent rendre le traitement plus complexe et prolonger la durée de la thérapie." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes avec les Cord Factors ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont possibles, surtout si l'infection n'est pas traitée rapidement." } }, { "@type": "Question", "name": "Quelles sont les conséquences à long terme des Cord Factors ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les conséquences peuvent inclure des lésions pulmonaires permanentes et des problèmes respiratoires." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les Cord Factors ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent l'immunodépression, le tabagisme et la malnutrition." } }, { "@type": "Question", "name": "Le VIH augmente-t-il le risque d'infection par Cord Factors ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le VIH affaiblit le système immunitaire, augmentant le risque d'infection tuberculeuse." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Le voyage dans des zones endommagées augmente-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à forte prévalence de tuberculose augmente le risque d'infection." } }, { "@type": "Question", "name": "Le contact avec des personnes infectées est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le contact étroit avec des personnes infectées augmente le risque de transmission." } } ] } ] }

Sources (10000 au total)

Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.

The Norwegian Trauma Registry (NTR) is designed to monitor and improve the quality and outcome of trauma care delivered by Norwegian trauma hospitals. Patient care is evaluated through specific qualit... We validated 49 of the 118 variables registered in the NTR by comparing those with the corresponding ones in electronic patient records for 180 patients with a trauma diagnosis admitted in 2019 at eig... Almost perfect agreement (AC... All tested variables in the Norwegian Trauma Registry displayed excellent agreement with the corresponding variables in electronic patient records. Variables in the registry that showed missing data n...

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.

One crucial obstacle to attaining universal immunization coverage in Sub-Saharan Africa is the paucity of timely and high-quality data. This challenge, in part, stems from the fact that many frontline... A descriptive cross-sectional study was conducted, involving health districts and health facilities in all 10 regions in Cameroon selected by a multi-stage sampling scheme. Structured questionnaires a... A total of 265 facilities in 68 health districts were assessed. There was limited availability of some data recording tools like vaccination cards (43%), maintenance registers (8%), and stock cards (5... Our findings unveil important gaps in data collection practices at the facility level that could adversely affect Cameroon's immunization data quality. It highlights the urgent need for systematic cap...

Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.

Although gene expression data play significant roles in biological and medical studies, their applications are hampered due to the difficulty and high expenses of gathering them through biological exp... In this study, an improved data augmentation approach MDWGAN-GP, a generative adversarial network model with multiple discriminators, is proposed. In addition, a novel method is devised for enriching ... The experimental results have demonstrated that compared with other state-of-the-art methods, the MDWGAN-GP method can produce higher quality generated gene expression data in most cases....

Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.

Ethnicity is an important variable, and in Aotearoa New Zealand it is used to monitor population health needs, health services outcomes and to allocate resources. However, there is a history of underc... Through individual record linkage, prospective self-reported ethnicity, collected using New Zealand Census and Ministry of Health - Manatū Hauora ethnicity protocol as a "gold standard", was compared ... Māori were undercounted in secondary NHI (32.5%) and primary care (31.3%) datasets compared to self-reported (34.6%). Between 9.5-11% of individuals had a different ethnicity recorded in health datase... Routine health datasets fail to adequately collect ethnicity, particularly for those with multiple ethnicities. Inaccuracies disproportionately affect Māori and urgent efforts are needed to improve co...

Drivers and Barriers to Improved Data Quality and Data-Use Practices: An Interpretative Qualitative Study in Addis Ababa, Ethiopia.

An objective of the Information Revolution Roadmap of Ethiopia's Health Sector Transformation Plan was to improve health management information system (HMIS) data quality and data use at the point of ... We conducted an interpretative qualitative study across all 11 health centers in 3 subcities of Addis Ababa, Ethiopia: Yeka, Akaki-Kaliti, and Ledeta. A total of 40 key informant interviews and 6 focu... Our findings indicate that the main drivers of data quality and use at the point of service delivery were the use of the Connected Woreda strategy and its tools, capacity-building activities including... Improvements in quality and use of HMIS data at health facilities are expected to result in delivering better-quality health services to the community as data enable health workers to identify gaps in...

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Routine clinical data from clinical charts are indispensable for retrospective and prospective observational studies and clinical trials. Their reproducibility is often not assessed. We developed a pr... For men with prostate cancer who had clinical-grade paired tumor-normal sequencing at a comprehensive cancer center, we performed team-based retrospective data collection from the electronic medical r... Data elements on demographics, diagnosis and staging, disease state at the time of procuring a genomically characterized sample, and clinical outcomes were piloted and then abstracted for 2261 patient... With a prostate cancer-specific data dictionary and quality control measures, manual clinical annotations by a multidisciplinary team can be scalable and reproducible. The data dictionary and the R pa...

Validation of Multi-State EHR-Based Network for Disease Surveillance (MENDS) Data and Implications for Improving Data Quality and Representativeness.

Surveillance modernization efforts emphasize the potential use of electronic health record (EHR) data to inform public health surveillance and prevention. However, EHR data streams vary widely in thei... We developed a validation process for the Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot project to identify and resolve data quality issues that could affect chronic disease pre... We identified gaps in the EHR databases of data contributors and in the processes to extract, map, integrate, and analyze their EHR data. Examples of source-data problems included missing data on race... Validation protocols identified critical errors in both EHR source data and in the processes used to transform these data for analysis. Our experience highlights the value and importance of data valid...